Merck | MRK - Ebitda


Merck reported EUR1.6B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Adidas EUR 867M 118M Jun/2026
Adyen EUR 641.54M 60.52M Jun/2026
Akzo Nobel EUR 388M 10M Sep/2026
Alcon AG USD 795M 478M Mar/2026
Amadeus IT EUR 672.8M 11.4M Jun/2026
Amarin USD 12.54M 28.57M Jun/2025
AstraZeneca USD 5.16B 510M Jun/2026
BASF EUR 2.45B 93M Jun/2026
Bayer EUR 2.14B 2.31B Jun/2026
Beiersdorf EUR 926M 58M Jun/2026
Covestro EUR 117M 125M Dec/2025
Danone EUR 2.57B 116M Dec/2025
Fresenius EUR 988M 37M Jun/2026
Fresenius Medical Care EUR 843.66M 19.66M Jun/2026
Genmab DKK 401M 186M Jun/2026
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 473M 120M Jun/2026
Henkel EUR 1.88B 139M Dec/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Infineon EUR 1.26B 158M Jun/2026
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Linde USD 3.44B 59M Mar/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.6B 69M Jun/2026
Novartis USD 8.62B 2.14B Sep/2026
Philips EUR 910M 343M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026
UCB EUR 1.6B 570M Dec/2025